Citadel Advisors’s Akari Therapeutics AKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-33,260
| Closed | -$99.1K | – | 5933 |
|
|
2024
Q3 | $99.1K | Buy |
+33,260
| New | +$99.1K | ﹤0.01% | 4928 |
|
|
2023
Q1 | – | Sell |
-772
| Closed | -$7.57K | – | 5877 |
|
|
2022
Q4 | $7.57K | Buy |
+772
| New | +$7.57K | ﹤0.01% | 5727 |
|
|
2022
Q3 | – | Sell |
-753
| Closed | -$15K | – | 5828 |
|
|
2022
Q2 | $15K | Buy |
+753
| New | +$15K | ﹤0.01% | 5763 |
|
|
2021
Q4 | – | Sell |
-1,889
| Closed | -$62K | – | 6395 |
|
|
2021
Q3 | $62K | Sell |
1,889
-724
| -28% | -$23.8K | ﹤0.01% | 6055 |
|
|
2021
Q2 | $90K | Buy |
2,613
+1,227
| +89% | +$42.3K | ﹤0.01% | 6008 |
|
|
2021
Q1 | $73K | Buy |
+1,386
| New | +$73K | ﹤0.01% | 5987 |
|
|
2020
Q3 | – | Sell |
-948
| Closed | -$41K | – | 4633 |
|
|
2020
Q2 | $41K | Buy |
+948
| New | +$41K | ﹤0.01% | 4414 |
|
|
2015
Q3 | – | Sell |
-76
| Closed | -$9K | – | 3976 |
|
|
2015
Q2 | $9K | Sell |
76
-67
| -47% | -$7.93K | ﹤0.01% | 3702 |
|
|
2015
Q1 | $22K | Buy |
+143
| New | +$22K | ﹤0.01% | 3509 |
|